About Careers Internship MedBlog Contact us

Drugs That Fight MERS-coronavirus Revealed

by Dr. Enozia Vakil on May 20, 2014 at 12:01 PM
 Drugs That Fight MERS-coronavirus Revealed

A number of existing pharmaceutical drugs and compounds under development may be effective against the Middle East Respiratory Syndrome, researchers have found.

In the first study, researchers screened a library of 290 pharmaceutical drugs, either FDA-approved or in advanced clinical development for antiviral activity against the MERS coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV) in cell culture. They found 27 compounds that were active against both viruses including some cancer drugs and antipsychotics.


Matthew Frieman of the University of Maryland Medical School said repurposing of approved pharmaceutical drugs for new indications presents an attractive alternative to the normal paradigm of huge library screening against a specific viral enzyme.

He said given development times and manufacturing requirements for new products, repurposing of existing drugs is likely the best solution to rapidly identify therapeutics for outbreaks due to emerging viruses.

In the second study, researchers collaborating in the European antiviral research program SILVER used a similar methodology to screen a library of 348 FDA-approved drugs for anti-MERS-CoV activity in cell culture. They identified four compounds that inhibited MERS-CoV, SARS-CoV and Human Coronavirus 229E at relatively low concentrations.

Two of the compounds were also identified by the U.S. study: the antimalarial drug chloroquine and the antipsychotic chlorpromazine.

The third and final study finds that an experimental compound, previously shown to block SARS-CoV replication, can inhibit replication of two other coronaviruses, MERS-CoV and mouse hepatitis virus.

The study has been published online in the journal Antimicrobial Agents and Chemotherapy.

Source: ANI
Font : A-A+



Recommended Readings

Latest Coronavirus News

Tau Proteins: Key Players in Understanding COVID-19 Brain Fog
In Alzheimer's disease patients, COVID-19 infection may exacerbate cognitive symptoms, including brain fog.
Early Convalescent Plasma Use May Reduce Severe COVID and Long COVID Risk
COVID-19 patients receiving early convalescent plasma treatment are less likely to develop post-COVID (long COVID) with SARS-CoV-2 antibodies.
The Return of Masks and Lockdowns
Discussions gain traction on the resurgence of masks and limited lockdowns this winter amid rising COVID variants.
Meeting the Challenge of Evolving COVID Strains
India stands prepared to develop vaccines for any new COVID strain, as stated by Indian Council of Medical Research (ICMR).
Rising Infectious Disease Threats Spur Expert Calls for Pandemic Readiness
While ongoing efforts in public awareness can curb COVID-19 resurgences, the lessons learned can shape a resilient and prepared global community.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Drugs That Fight MERS-coronavirus Revealed Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests